We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Liberty Global Class A
LBTYA
$3.31B
| $9.23M | 0.07% |
270,177
-39,881
| -13% | -$1.27M |
|
302
RPC Inc
RES
$1.24B
| $9.07M | 0.06% |
+539,905
| New | +$8.2M |
|
|
LN
303
DELISTED
LINE Corporation
LN
| $9.05M | 0.06% |
+187,001
| New | +$7.96M |
|
|
QGENF
304
DELISTED
QIAGEN NV
QGENF
| $9.01M | 0.06% |
328,456
+148,941
| +83% | +$4.09M |
|
305
PUT
Sarepta Therapeutics
SRPT
$1.66B
| $8.96M | 0.06% |
+210,000
| New | +$6.35M |
|
|
SPN
306
DELISTED
Superior Energy Services, Inc.
SPN
| $8.85M | 0.06% |
49,444
+27,991
| +130% | +$4.69M |
|
|
PXD
307
DELISTED
Pioneer Natural Resource Co.
PXD
| $8.82M | 0.06% |
47,527
-270,129
| -85% | -$46M |
|
|
MRT
308
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $8.68M | 0.06% |
+738,877
| New | +$8.62M |
|
309
Microsoft
MSFT
$2.84T
| $8.62M | 0.06% |
149,684
-445,622
| -75% | -$25.2M |
|
|
VA
310
DELISTED
Virgin America Inc.
VA
| $8.62M | 0.06% |
161,054
+83,664
| +108% | +$4.66M |
|
311
FIVE9
FIVN
$1.77B
| $8.59M | 0.06% |
+547,994
| New | +$7.48M |
|
312
Atmos Energy
ATO
$29.9B
| $8.56M | 0.06% |
114,969
-50,268
| -30% | -$3.87M |
|
|
VTLE
313
DELISTED
Vital Energy
VTLE
| $8.52M | 0.06% |
33,004
+25,879
| +363% | +$5.9M |
|
|
CELG
314
DELISTED
Celgene Corp
CELG
| $8.28M | 0.06% |
79,245
+8,875
| +13% | +$961K |
|
315
Hartford Financial Services
HIG
$38.5B
| $8.22M | 0.06% |
191,918
+187,058
| +3,849% | +$7.83M |
|
316
Halliburton
HAL
$27.9B
| $8.21M | 0.06% |
183,057
+144,335
| +373% | +$6.3M |
|
317
Cheesecake Factory
CAKE
$4.21B
| $8.12M | 0.06% |
162,234
+93,058
| +135% | +$4.75M |
|
|
VMW
318
DELISTED
VMware, Inc
VMW
| $8.1M | 0.06% |
110,446
+103,023
| +1,388% | +$7.25M |
|
319
Revvity
RVTY
$12.3B
| $8.03M | 0.06% |
143,132
+127,795
| +833% | +$6.97M |
|
320
PENN Entertainment
PENN
$2.74B
| $8.03M | 0.06% |
591,688
+173,591
| +42% | +$2.44M |
|
|
WBT
321
DELISTED
Welbilt, Inc.
WBT
| $8.03M | 0.06% |
494,956
+385,900
| +354% | +$6.59M |
|
322
Core Laboratories
CLB
$538M
| $7.92M | 0.06% |
70,502
-136,875
| -66% | -$15.8M |
|
323
AstraZeneca
AZN
$263B
| $7.89M | 0.06% |
+120,093
| New | +$7.85M |
|
|
BMCH
324
DELISTED
BMC Stock Holdings, Inc
BMCH
| $7.74M | 0.06% |
+436,749
| New | +$8.51M |
|
325
Hershey
HSY
$35.4B
| $7.71M | 0.05% |
+80,661
| New | +$8.53M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.